| 000 | 03062nam a22004575i 4500 | ||
|---|---|---|---|
| 001 | 60626 | ||
| 005 | 20200226102407.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 170614s2017 si | s |||| 0|eng d | ||
| 020 |
_a9789811038860 _9978-981-10-3886-0 |
||
| 024 | 7 |
_a10.1007/978-981-10-3886-0 _2doi |
|
| 035 | _a(DE-He213)978-981-10-3886-0 | ||
| 050 | 4 | _aRB45 | |
| 072 | 7 |
_aMJF _2bicssc |
|
| 072 | 7 |
_aMED038000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.15 _223 |
| 245 | 1 | 0 |
_aHematological Disorders in Children _h[electronic resource] : _bPathogenesis and Treatment / _cedited by Eiichi Ishii. |
| 264 | 1 |
_aSingapore : _bSpringer Singapore : _bImprint: Springer, _c2017. |
|
| 300 |
_aX, 269 p. 24 illus., 6 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aPart I: Hematopoiesis -- Hematopoietic Stem Cells -- Part II: White Blood Cell Disorders -- Acute Lymphoblastic Leukemia -- Acute Myeloid Leukemia -- Myelodysplastic syndrome and JMML -- Leukopenia (neutropenia) -- Part III: Red Blood Cell Disorders -- Aplastic Anemia -- Bone marrow failure, TAM -- Part IV: Platelet and Coagulation Disorders -- Immune and inherited thrombocytopenia -- Hemophilia -- Thrombosis -- Part V: Histiocytic Disorders -- Langerhans Cell Histiocytosis -- Hemophagocytic Lymphohistiocytosis, primary -- Hemophagocytic Lymphohistiocytosis, secondary. | |
| 520 | _aThis book describes the pathogenesis and treatment of several representative hematological disorders in children, with a special focus on genetic and molecular aspects. Research on the pathogenesis of hematological disorders in children has made remarkable strides; especially molecular target therapy has shown outstanding effects in refractory and conventional therapies for childhood leukemia. The findings presented in this book will broaden readers’ understanding and hopefully spark new discussions leading to the development of new therapies including cell therapy and molecular target therapy, allowing clinicians to use more effective and less toxic approaches in the future. Hematological Disorders in Children will appeal to a wide readership, from medical students and beginning investigators to experienced scholars in the field of pediatric hematology and oncology seeking to broaden their understanding and keep up with the latest developments. It will also be of interest to the parents of pediatric patients, and to co-medical staffs. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aHematology. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aPediatrics. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aHematology. |
| 650 | 2 | 4 | _aPediatrics. |
| 650 | 2 | 4 | _aOncology. |
| 700 | 1 |
_aIshii, Eiichi. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789811038853 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-981-10-3886-0 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c3326 _d3326 |
||